Search - tctmd.com

Displaying 701 - 720 of 1148

Sort: Relevancy | Date

News Industry News

STENTYS Reallocates Resources to focus on its Advanced Drug-Eluting Stent Program

July 31, 2014

News Industry News

Cook Medical's Zilver® PTX® Drug-Eluting Stent selected as a top emerging health technology in Canada

July 25, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Industry News

Boston Scientific Receives FDA Approval for REBEL™ Platinum Chromium Coronary Stent System

July 21, 2014

News Industry News

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

July 16, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Industry News

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

June 19, 2014

News Industry News

Cook Medical makes Zilver® PTX® drug-eluting stent available in Canada

June 05, 2014

News Industry News

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

June 04, 2014

News Daily News

Nationwide Registry Shows Trends in DES Use Over a Decade

June 02, 2014

News Daily News

Nobori BES Equals Promus Element in Long Lesions

Jason Kahn

May 30, 2014

News Daily News

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

Jason Kahn

May 30, 2014

News Industry News

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

May 29, 2014

News Industry News

Postmarket surveillance study in Japan confirms benefits of Cook Medical's Zilver® PTX® stent

May 29, 2014

News Industry News

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 21, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

May 20, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

May 20, 2014

Advertisement

STENTYS Reallocates Resources to focus on its Advanced Drug-Eluting Stent Program

Cook Medical's Zilver® PTX® Drug-Eluting Stent selected as a top emerging health technology in Canada

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Boston Scientific Receives FDA Approval for REBEL™ Platinum Chromium Coronary Stent System

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

Cook Medical makes Zilver® PTX® drug-eluting stent available in Canada

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

Nationwide Registry Shows Trends in DES Use Over a Decade

Nobori BES Equals Promus Element in Long Lesions

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

Postmarket surveillance study in Japan confirms benefits of Cook Medical's Zilver® PTX® stent

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content